AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne
Go back to AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne| Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) | Delayed: 18.66 -0.15 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.81 | 52 Week High | $27.10 | |||
| Open | $19.12 | 52 Week Low | $24.10 | |||
| Day High | $19.32 | P/E | N/A | |||
| Day Low | $18.65 | EPS | $0.00 | |||
| Volume | 3,464,757 | |||||
| Alabama Power Co. 5.875% Sr. Notes Series 2007B (NASDAQ: ALM) | Delayed: 18.66 -0.15 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.81 | 52 Week High | $27.10 | |||
| Open | $19.12 | 52 Week Low | $24.10 | |||
| Day High | $19.32 | P/E | N/A | |||
| Day Low | $18.65 | EPS | $0.00 | |||
| Volume | 3,464,757 | |||||

